Innovation in Duodenoscope Design: Opportunities with single-use scopes beyond infection control
Inside Scope
by American Gastroenterological Association (AGA)
1M ago
Uzma Siddiqui, MD, is here to host episode 3 of our series Innovation in Duodenoscope Design! She’s joined by Amrita Sethi, MD, to discuss opportunities with single-use scopes beyond infection control, with a focus on ergonomic design. They’ll talk through how disposable scopes impact workflow both on and off the unit. Continue listening for a discussion on advantages and disadvantages of the widespread use of disposable scopes now and in the future. This series is supported by an unrestricted educational grant from Boston Scientific. To find additional resources and learn more about Innovatio ..read more
Visit website
Innovation in Duodenoscope Design: Are disposable scopes the answer?
Inside Scope
by American Gastroenterological Association (AGA)
1M ago
Episode 2 of our new series Innovation in Duodenoscope Design is all about disposable scopes! Join host Adarsh Thaker, MD, and his guests Gregory A. Cote, MD, and Andrew Ross, MD, as they cover: • How to determine whether a scope is clean or not and how to know it is ready for the next patient. • Cost and reimbursement factors into declaring that the risk of exogenous is "low". • If single use duodenoscopes make sense not only in infection prevention but also in the cost to the environment. This series is supported by an unrestricted educational grant from Boston Scientific. To find additional ..read more
Visit website
Innovation in Duodenoscope Design: FDA’s approach to post-market surveillance
Inside Scope
by American Gastroenterological Association (AGA)
1M ago
Welcome to our new series Innovation in Duodenoscope Design! Episode one is hosted by Adarsh Thaker, MD. He is joined by Shani Haugen, PhD, who will help us understand how the FDA is addressing duodenoscope-related infection issues. They’ll answer key questions like what do FDA’s Safety Communications mean for GIs, what have we learned from 522 studies, and what do we still have to learn? This series is supported by an unrestricted educational grant from Boston Scientific. To find additional resources and learn more about Innovation in Duodenoscope Design, visit scopeinnovation.gastro.org ..read more
Visit website
Innovation in Duodenoscope Design: Making sense of endoscope reprocessing guidelines
Inside Scope
by American Gastroenterological Association (AGA)
1M ago
Welcome to the final episode of our series Innovation in Duodenoscope Design. Guest host Nina Nandy, MD, is joined by Michael L. Kochman, MD, AGAF, to discuss the recently published multisociety guideline on reprocessing flexible GI endoscopes and if the recommendations put forth are sufficient to address the current challenges posed by duodenoscope-related infections. This series is supported by an unrestricted educational grant from Boston Scientific. To find additional resources and learn more about Innovation in Duodenoscope Design, visit scopeinnovation.gastro.org ..read more
Visit website
BONUS: Help your patients with nonalcoholic fatty liver disease (NAFLD) lose weight
Inside Scope
by American Gastroenterological Association (AGA)
5M ago
This special episode of Small Talk, Big Topics shares key insights from the AGA Clinical Practice Update on Lifestyle Modification Using Diet and Exercise to Achieve Weight Loss in the Management of Nonalcoholic Fatty Liver Disease. This episode is hosted by Dr. Jana Al Hashash, member of the AGA Clinical Practice Update Committee. She is joined by: -Dr. Heather Patton, NAFLD expert and past member of the AGA Clinical Practice Update Committee -Dr. Joseph K. Lim, past chair of the AGA Clinical Practice Update Committee and co-author of this CPU -Dr. Zobair M Younossi, co-author of this CPU To ..read more
Visit website
Biosimilars: Managing switch scenarios with biologics and biosimilars
Inside Scope
by American Gastroenterological Association (AGA)
5M ago
Welcome to our four-part series Biosimilars: Addressing the Knowledge Gaps, hosted by Drs. Christina Ha and Frank Scott. Each episode features a challenging patient case and short discussion. In episode 2 of 4, we’ll discuss: • How do you prepare your team and the patient for a switch to a biosimilar? • Are there any situations where switching is not appropriate? • What do you think about multiple switches? • How do you minimize the potential for a nocebo effect? This series is supported by independent medical education grants from Amgen and Pfizer. To collect CME credit for listening, visit a ..read more
Visit website
Biosimilars: Communicating with a patient who does not want to switch
Inside Scope
by American Gastroenterological Association (AGA)
5M ago
Welcome to our four-part series Biosimilars: Addressing the Knowledge Gaps, hosted by Dr. Christina Ha. Each episode features a challenging patient case and short discussion. In episode 4 of 4, we're joined by guests Shuba Bhat, PharmD, and Miguel Regueiro, MD, to discuss: • Their approach to shared decision-making with a patient that’s concerned about a switch. And how often does this occur? • Do you suggest that the patient speak with multiple team members? • As a clinical pharmacist how do you counsel these patients? • What is the general approach to switching used at Cleveland Clinic and w ..read more
Visit website
Biosimilars: The logistics of switching between biosimilars or between biosimilars and reference product
Inside Scope
by American Gastroenterological Association (AGA)
5M ago
Welcome to our four-part series Biosimilars: Addressing the Knowledge Gaps, hosted by Dr. Christina Ha. Each episode features a challenging patient case and short discussion. In episode 3 of 4, we're joined by guests Shuba Bhat, PharmD, and Jennifer Seminerio-Diehl, MD, to discuss: • What are the practical logistics when you work on a switch with a patient? • How do you address a situation where a patient says they are experiencing an increase in symptoms after a switch? • Are there any situations where you would consider appealing an insurance decision and not switching? • What tests do you u ..read more
Visit website
Biosimilars: Starting a patient on biologic therapy
Inside Scope
by American Gastroenterological Association (AGA)
6M ago
Welcome to our four-part series Biosimilars: Addressing the Knowledge Gaps, hosted by Drs. Christina Ha and Frank Scott. Each episode features a challenging patient case and short discussion. In episode 1 of 4, we’ll discuss: • How do you explain biosimilars to a patient with moderate-to-severe Crohn’s disease when you start them on a biologic? • What are some of the common questions that patients ask and how do you address them? • Do you set goals of therapy with your patients and what are they? This series is supported by independent medical education grants from Amgen and Pfizer. To collect ..read more
Visit website
BONUS: Microbiota changes associated with C. difficile infection
Inside Scope
by American Gastroenterological Association (AGA)
7M ago
In honor of C. diff Awareness Month, we're launching two bonus episodes from our upcoming program: C. difficile: Preparing the Field for Change. This program will explore how to take a patient-centered approach to treatment and diagnosis, explore emerging treatment options, and discuss best practices for transitions of care. In this bonus episode, Drs. Paul Feuerstadt and Sahil Khanna describe the shifts in the microbiota with C. difficile infection. This series is supported by an educational grant from Ferring Pharmaceuticals, Inc ..read more
Visit website

Follow Inside Scope on Feedspot

Continue with Google
Continue with Apple
OR